Denna svenska version av medivir.com innehåller endast översättningar av utvalda delar av innehållet från engelska sidan. För fullständig information och tillgång till komplett innehåll hänvisar vi till medivir.com-sidan.
Medivir is a drug discovery and development company focusing on transformative cancer drugs. Our research and development are based on our extensive expertise in protease inhibitor design and nucleoside/nucleotide science.
Medivir focuses on cancers of high unmet medical need to provide benefit to patients who so far have had few treatment options.Our projects >
Thanks to our scientific knowledge, balanced project portfolio, collaborative culture and extensive industry experience we do this efficiently and with a high success rate.Partnership >
Partnering is an important element of our business strategy. Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale.